Your browser doesn't support javascript.
loading
Tea polyphenols benefit vascular function.
Yung, L M; Leung, F P; Wong, W T; Tian, X Y; Yung, L H; Chen, Z Y; Yao, X Q; Huang, Y.
Afiliación
  • Yung LM; Institute of Vascular Medicine and Department of Physiology, Chinese University of Hong Kong Shatin, NT, Hong Kong.
Inflammopharmacology ; 16(5): 230-4, 2008 Oct.
Article en En | MEDLINE | ID: mdl-18815738
ABSTRACT
Tea, the most popular beverage worldwide, is consumed in three basic forms; green tea, black tea and oolong tea. Tea contains over 4,000 chemicals some of which are bioactive. In recent years there has been a mounting interest in understanding the cardiovascular and metabolic benefits of polyphenolic flavonoids in tea, which can be used as a supplement among patients. Diverse cardioprotective effects of consuming tea or tea polyphenols have been described on pathological conditions, e. g. hypertension, atherosclerosis, diabetics, hypercholesterolemia, obesity, and are attributed to antioxidative, anti-thrombogenic, anti-inflammatory, hypotensive and hypocholesterolemic properties of tea polyphenols. This review focuses on cardiovascular benefits of tea polyphenols based on in vitro and in vivo studies on experimental animal models and on studies of human subjects in four areas (1) vasorelaxant effect; (2) protective effect against endothelial dysfunction; (3) antioxidant effect and (4) hypolipidemic effect. We will briefly discuss the effects of tea on atherosclerosis and hypertension.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fenoles / Té / Flavonoides / Aterosclerosis / Hipertensión Límite: Animals / Humans Idioma: En Revista: Inflammopharmacology Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2008 Tipo del documento: Article País de afiliación: Hong Kong Pais de publicación: CH / SUIZA / SUÍÇA / SWITZERLAND

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fenoles / Té / Flavonoides / Aterosclerosis / Hipertensión Límite: Animals / Humans Idioma: En Revista: Inflammopharmacology Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2008 Tipo del documento: Article País de afiliación: Hong Kong Pais de publicación: CH / SUIZA / SUÍÇA / SWITZERLAND